Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: Improved efficacy with higher dosing

被引:20
作者
Abshire, TC
机构
[1] Emory Univ, Sch Med, AFLAC Canc & Blood Disorders Serv, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Comprehens Hemophilia Program, Atlanta, GA 30322 USA
关键词
D O I
10.1053/j.seminhematol.2003.11.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3 / 7
页数:5
相关论文
共 24 条
[1]  
Allen GA, 2002, CAN J ANAESTH, V49, pS7
[2]   The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation [J].
Allen, GA ;
Monroe, DM ;
Roberts, HR ;
Hoffman, M .
BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S3-S7
[3]  
[Anonymous], BLOOD COAGUL FIBRINO
[4]   FIBRIN IN HUMAN PLASMA - GEL ARCHITECTURES GOVERNED BY RATE AND NATURE OF FIBRINOGEN ACTIVATION [J].
BLOMBACK, B ;
CARLSSON, K ;
FATAH, K ;
HESSEL, B ;
PROCYK, R .
THROMBOSIS RESEARCH, 1994, 75 (05) :521-538
[5]   Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures [J].
Cooper, HA ;
Jones, CP ;
Campion, E ;
Roberts, HR ;
Hedner, U .
HAEMOPHILIA, 2001, 7 (05) :517-522
[6]   Pharmacokinetics of recombinant activated factor VII (rFVIIa) [J].
Erhardtsen, E .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (04) :385-391
[7]   Recombinant factor Vlla (NovoSeven®) as a hemostatic agent [J].
Hedner, U .
DM DISEASE-A-MONTH, 2003, 49 (01) :39-48
[8]  
Hoffman M, 1998, BLOOD COAGUL FIBRIN, V9, pS61
[9]  
Ingerslev J, 1998, BLOOD COAGUL FIBRIN, V9, pS107
[10]   A new approach to treatment of bleeding episodes in young hemophilia patients:: a single bolus megadose of recombinant activated factor VII (NovoSeven®) [J].
Kenet, G ;
Lubetsky, A ;
Luboshitz, J ;
Martinowitz, U .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (03) :450-455